TP53 and cancer: Therefore, the negative correlation between the expression levels of TRPV1 and the enrichment scores of the p53 pathway could be attributed to the inhibitory effect of TRPV1 on cancer progression that reduces the stimulatory upregulation of the p53 pathway.